Tom Price Considering Ending Birth Control Mandate
As Republicans move to repeal and replace the Affordable Care Act (ACA), HHS Secretary Tom Price, MD, may be eyeing the ACA’s birth control mandate, reported The Hill. As a congressman, Price opposed the mandate, which requires insurance companies cover free contraception. Reversing the mandate could be as easy as HHS excluding birth control from the list of women’s preventive health services that must be provided with no cost sharing.
Harvard Pilgrim Signs 2 New Pay-for-Performance Contracts
In Massachusetts, Harvard Pilgrim Health Care has signed 2 value-based contracts to pay for expensive drugs. Boston Globe reported that the deals are for Enbrel, a rheumatoid arthritis drug that costs about $45,000 a year, and Forteo, an osteoporosis drug that costs about $29,000 a year. The Enbrel contract is for 2 years and includes 6 criteria, while the Forteo contract allows Harvard Pilgrim to pay less for the drug over time if patients take it for 2 years.
Texas Cannot Cut Medicaid Funding to Planned Parenthood
Texas has become the latest state where an attempt to cut Medicaid funding to Planned Parenthood has been blocked. According to The New York Times, a federal judge temporarily blocked the state’s efforts because of a lack of evidence that Planned Parenthood providers violated medical or ethical standards. The state’s attorney general said Texas will appeal the injunction.
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More